Company intelligence / Profile preview

Cypress Bioscience, Inc.

San Diego, California, United Statesuk.marketscreener.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cypress Bioscience developed two FDA-approved products—Prosorba™ for rheumatoid arthritis and Savella® (milnacipran HCl) for fibromyalgia. Its pipeline included CNS-focused assets such as CYP‑1020 for cognitive impairment in schizophrenia, Staccato® nicotine for smoking cessation, and intranasal carbetocin for autism. After its acquisition by Ramius LLC and Royalty Pharma in 2010–2011, most development programs were discontinued or shelved

Therapeutic areas: PulmonologyImmunologyPsychiatryRheumatologyNeurology
Modalities: Small moleculesMedical devices (e.g., Prosorba™)
Industry: Biotech

Drug pipeline

3 assets

milnacipran

Commercial

Indications: Fibromyalgia

2 more assets in the full pipeline.

Request access →

Partnerships

Royalty Pharma acquired rights to Savella royalties through this transaction. No other major partnerships noted at the time of acquisition.

Beyond the preview

Go deeper on Cypress Bioscience, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cypress Bioscience, Inc..

Explore the full profile